cells expressing Gata1 are negatively selected in vivo (Supplementary Figure S4b) . Together these data demonstrated that Gata1 expression is deleterious to mutant IDH2 AML cells.
ZDHHC11 and ZDHHC11B are critical novel components of the oncogenic MYC-miR-150-MYB network in Burkitt lymphoma Leukemia (2017) 31, 1470-1473; doi:10.1038/leu.2017.94
Burkitt lymphoma (BL) is an aggressive subtype of B-cell non-Hodgkin lymphoma that most frequently affects young children. 1 BL is characterized by a chromosomal translocation involving the MYC gene locus resulting in overexpression of MYC. 2 MYC is a transcription factor involved in cell growth, proliferation and maintenance of stem cell-like properties. 3, 4 Besides protein-coding genes, MYC also regulates the expression of multiple microRNAs (miRNAs) and long non-coding RNAs. 5, 6 In a previous study, 7 we identified a MYC-related miRNA expression profile in pediatric BL as compared to MYClow chronic lymphocytic leukemia. In this study, we further examined the role of MYC-repressed miRNAs on growth of BL cells.
Accepted article preview online 23 March 2017; advance online publication, 7 April 2017 Eleven miRNAs were significantly differentially expressed between Burkitt lymphoma (BL) and chronic lymphocytic leukemia (CLL) with more than fourfold difference (Supplementary Figure S1a) . The differences in miRNA levels were validated by quantitative reverse transcription PCR (qRT-PCR), and MYC regulation was confirmed using the P493-6 B-cell line, which harbors a tetracycline-repressible myc allele 8 ( Supplementary  Figures S1b-d) .
Next, we determined whether the MYC-repressed miRNAs influence BL cell growth. All six miRNAs that we could stably overexpress, affected growth of BL cells. Ectopic expression of miR-26a, miR-26b and miR-150 strongly reduced cell growth, similar to MYC inhibition (Supplementary Figures S2a-c) . These results were confirmed in two independent biological replicates in the ST486 and DG75 BL cell lines ( Supplementary  Figures S2d and e) . We have chosen to further investigate the role of miR-150 in BL, a miRNA with an important regulatory role in hematopoiesis. 9 To identify miR-150 target genes, we performed AGO2 Table S1 ). Among them we found MYB, a validated target of miR-150. 10 qRT-PCR for the five genes with the highest increase in IP enrichment upon miR-150 overexpression confirmed the microarray results ( Supplementary  Figures S3e and f) .
The two genes with the highest IP enrichment in miR-150-cells compared to EV cells were ZDHHC11 and ZDHHC11B. These two highly homologous genes are located on chr5q15 separated by~25 kb. Both genes encode protein-coding and non-coding transcripts ( Figure 1a ). The protein products of ZDHHC11 and ZDHHC11B are poorly characterized members of a palmitoyltransferase family.
11 Both protein-coding and non-coding ZDHHC11 transcripts are expressed in BL cell lines. The ZDHHC11B non-coding transcript is expressed in BL cells, whereas the coding variant is below the detection limit of Figure 1 . ZDHHC11 and ZDHHC11B are novel targets of miR-150 essential for the growth of BL cells. (a) ZDHHC11 and ZDHHC11B genes encode for protein-coding (blue) and non-coding (green) transcripts. The 3′ regions of ZDHHC11 and ZDHHC11B contain tandemly repeated miR-150 binding sites (18 and 62, respectively). Consensus sequence of the miR-150 binding sites in ZDHHC11 and ZDHHC11B is shown. A circular RNA is generated from the ZDHHC11 locus. RT-PCR in BL cell lines with divergent primers located in the last exon of ZDHHC11 revealed a circular transcript consisting of exons 12 and 13, exon 13 being 129 nt longer than annotated for the linear transcript (light gray box). Presence of the circular transcript was confirmed with two additional indicated primer sets. See also Supplementary Figure S4. (b) ST486 and DG75 cell lines were transfected with psiCheck2-ZDHHC11 or psiCheck2-ZDHHC11B, and miRNA negative control precursor or pre-miR-150-5p (left graph). Average Renilla/firefly luciferase ratio (RL/FL) from three independent experiments is shown ± s.d., values for the negative control were set to 1 (two-sided t-test, **P o 0.01; ****P o 0.0001). ST486 cells were transduced with miR-150 overexpression vector or control EV (middle and right graph). ZDHHC11/B mRNA was quantified by qRT-PCR relative to U6. ZDHHC11 protein levels were quantified relative to the total protein. qRT-PCR. ZDHHC11 levels are much higher in BL cell lines than ZDHHC11B (Supplementary Figure S4a) . Expression of ZDHHC11 and ZDHHC11B is significantly higher in primary BL cases compared to CLL, consistent with the low miR-150 levels in BL (Supplementary Figure S4b) . The 3′ regions of both genes contain a strikingly high number of tandemly repeated miR-150 binding sites (BS): 18 in ZDHHC11 and 62 in ZDHHC11B. The consensus sequence of the miR-150 BS is CACAGUACUGGGAAUUGGGAG, with differences in one to four nucleotides between individual repeats. Complementarity of miR-150-5p to ZDHHC11 and ZDHHC11B extends beyond the 6-mer seed region enhancing the miRNA-RNA interaction (Figure 1a) . The dbSNP database reports several indel polymorphisms of one or more of the miR-150 BS repeats in both ZDHHC11 and ZDHHC11B. Screening of the miR-150 BS region by PCR revealed a variation in the length of the repeat region both in lymphoma cell lines and control samples (Supplementary Figure S4c) .
To confirm that ZDHHC11 and ZDHHC11B are targeted by miR-150, we cloned the 18 miR-150 BS of ZDHHC11 and the 62 miR-150 BS of ZDHHC11B into the psiCheck2 luciferase vector. Co-transfection of the constructs along with miR-150-5p precursor into ST486 and DG75 cells resulted in significantly lower relative luciferase activity (35-60% decrease) compared to the negative control. Moreover, ZDHHC11 mRNA and protein levels were downregulated upon miR-150 overexpression (Figure 1b) .
The high number of miR-150 BS suggested that ZDHHC11 and ZDHHC11B could function as endogenous sponges. Since circular RNA transcripts containing high number of miRNA binding sites have been described, 12, 13 we set out to identify potential circular transcripts arising from the ZDHHC11 and ZDHHC11B loci. We designed divergent primers located at the ends of the last exon of ZDHHC11 and ZDHHC11B, which contains the miR-150 BS region. The resulting PCR product from ST486 and DG75 cells contained the two last ZDHHC11 exons joined by back-splicing, with 129 additional nucleotides downstream of the last exon. Presence of circ-ZDHHC11 was confirmed with two additional primer sets (Figure 1a) . The circ-ZDHHC11 was also present in primary BL cases, albeit at variable levels (Supplementary Figure S4d) . Despite much lower circ-ZDHHC11 levels compared to the linear ZDHHC11 transcripts, its enrichment in the AGO2-IP fraction of DG75-miR-150 cells was more pronounced (13.6-fold compared to EV) than the linear protein-coding (1.6-fold) and non-coding (3.3-fold) transcripts (Supplementary Figure S4e) . Altogether, this suggests that the non-coding ZDHHC11 and ZDHHC11B transcripts, especially the circular RNA, are efficiently targeted by miR-150 and could function as an endogenous sponge for this miRNA.
We next explored whether ZDHHC11, ZDHHC11B and MYB are involved in the strongly impaired growth of BL cells observed upon miR-150 overexpression. Short hairpin RNA (shRNA) knockdown of MYB severely impaired growth of ST486 cells, even stronger than miR-150 overexpression, demonstrating high dependency of BL cell growth on MYB (Figure 1c) . Downregulation of ZDHHC11 and ZDHHC11B with three shRNAs targeting all transcript variants of ZDHHC11/B also resulted in a significantly reduced cell growth, with a 33-91% decrease in GFP + cells after 22 days (Figure 1c, Supplementary Figure S5) . Remarkably, MYB protein levels were also decreased by 19-46% in ST486 cells upon ZDHHC11/B knockdown and the strength of the phenotype induced by individual ZDHHC11/B shRNAs correlated with the degree of MYB downregulation (Figure 1c) . In DG75 cells, downregulation of MYB and ZDHHC11/B also copied the phenotype of miR-150 overexpression (Supplementary Figure S6) . The observed effect of ZDHHC11/B downregulation on BL cell growth and MYB levels can be reconciled by a model in which ZDHHC11 and ZDHHC11B function as miR-150 sponges or competing endogenous RNAs.
14 Alternatively, the ZDHHC11 palmitoyltransferase protein can be involved. Palmitoylation affects protein localization and protein-protein interactions, 11 and there is some evidence for a role of palmitoylation in hematological malignancies. 15 Finally, we explored the relevance of the miR-150-ZDHHC11/ B-MYB network for other types of lymphoma. Expression analysis of the individual network components in a panel of diffuse large B-cell, Hodgkin and Burkitt lymphoma cell lines in comparison to germinal center B-cells (GCB) revealed that MYC, ZDHHC11/B and MYB are upregulated and miR-150 is downregulated in all lymphoma types as compared to GCB (Figure 2a ). This pattern is similar to that observed in P493-6 cells upon induction of MYC (Figure 2a) , which suggests that MYC regulates all three components. Overall, these data show that the relevance of our findings likely extends beyond BL.
In summary, our results establish a novel network involving MYC, miR-150, ZDHHC11, ZDHHC11B and MYB that promotes proliferation of BL cells (Figure 2b ). We propose that MYC ensures elevated levels of MYB required for the high proliferation rate of BL cells via two mechanisms. First, MYC downregulates miR-150 to unleash MYB from the miR-150-mediated repression. Second, MYC induces ZDHHC11 and ZDHHC11B that further ensures the maintenance of high MYB levels. Together, our results demonstrate a key role for ZDHHC11 and ZDHHC11B in maintaining the oncogenic MYC-miR-150-MYB axis in BL.
